InsidersTradesSigma
Track the 엘앤케이바이오 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 엘앤케이바이오 has logged 3 reports. Market capitalisation: €75.8bn. The latest transaction was disclosed on 6 July 2026 (Purchase). Among the most active insiders: 강국진. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
엘앤케이바이오 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones biofarmacéuticas.